FENC
Fennec Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.52
-0.11 ▼ -1.44%
🌙 3월 13일 6:30 PM ET (한국 3/14 07:30)
$7.91
+0.39 ▲ +5.19%
| Index | RUT | P/E | - | EPS (ttm) | -0.24 | Insider Own | 14.13% | Shs Outstand | 0.03B | Perf Week | -2.34% |
| Market Cap | 0.26B | Forward P/E | 11.42 | EPS next Y | 608.02% | Insider Trans | -22.43% | Shs Float | 0.03B | Perf Month | -3.84% |
| Enterprise Value | 0.25B | PEG | - | EPS next Q | 0.04 | Inst Own | 56.72% | Short Float | 2.81% | Perf Quarter | 1.08% |
| Income | -0.01B | P/S | 6.62 | EPS this Y | - | Inst Trans | 7.47% | Short Ratio | 5.95 | Perf Half Y | -16.72% |
| Sales | 0.04B | P/B | - | EPS next 5Y | - | ROA | -12.15% | Short Interest | 0.82M | Perf YTD | -2.34% |
| Book/sh | -0.16 | P/C | 11.7 | EPS past 3/5Y | 71.16% 52.21% | ROE | - | 52W High | -24.19% ($9.92) | Perf Year | 22.68% |
| Cash/sh | 0.64 | P/FCF | - | Sales past 3/5Y | - | ROIC | -48.29% | 52W Low | 60.68% ($4.68) | Perf 3Y | -8.96% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -521.41% | Gross Margin | 93.12% | Volatility(W/M) | 7.67% 6.23% | Perf 5Y | -2.34% |
| Dividend TTM | - | EV/Sales | 6.52 | Sales Y/Y TTM | -21.39% | Oper. Margin | -12.02% | ATR (14) | 0.48 | Perf 10Y | 321.05% |
| Dividend Ex-Date | - | Quick Ratio | 4.44 | EPS Q/Q | 89.07% | Profit Margin | -16.95% | RSI (14) | 39.11 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.69 | Sales Q/Q | 78.69% | SMA20 | -9.46% ($8.31) | Beta | 0.83 | Target Price | $15.33 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -5.21% ($7.93) | Rel Volume | 0.65 | Prev Close | $7.63 |
| Employees | 32 | LT Debt/Eq | - | EPS/Sales Surpr. | 9.09% 11.3% | SMA200 | -9.11% ($8.27) | Avg Volume(3M) | 0.14M | Price | $7.52 |
| IPO | 2003/10/22 | Option/Short | Yes/Yes | Trades | 1659 | Volume | 90,020 | Change | -1.44% |
뉴스 로딩 중...